Round Rock Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Round Rock Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$283K	Sell	2,219 -60	-3%	-$7.49K	0.04%	268
2025 Q4	$278K	Sell	2,279 -46	-2%	-$5.27K	0.04%	281
2025 Q3	$233K	Sell	2,325 -3,815	-62%	-$344K	0.04%	287
2025 Q2	$509K	Buy	+6,140	New	+$490K	0.09%	135
2024 Q1	–	Sell	-2,564	Closed	-$229K	–	194
2023 Q4	$229K	Buy	+2,564	New	+$190K	0.06%	169
2023 Q3	–	Sell	-2,958	Closed	-$246K	–	147
2023 Q2	$246K	Sell	2,958 -3,883	-57%	-$325K	0.09%	126
2023 Q1	$521K	Sell	6,841 -184	-3%	-$15.3K	0.2%	86
2022 Q4	$583K	Buy	7,025 +428	+6%	+$34.7K	0.24%	76
2022 Q3	$523K	Buy	6,597 +1,604	+32%	+$135K	0.24%	75
2022 Q2	$371K	Buy	4,993 +2,410	+93%	+$181K	0.17%	90
2022 Q1	$232K	Sell	2,583 -267	-9%	-$24.7K	0.09%	125
2021 Q4	$319K	Buy	+2,850	New	+$344K	0.14%	92
2021 Q3	–	Sell	-2,047	Closed	-$277K	–	69
2021 Q2	$277K	Sell	2,047 -910	-31%	-$120K	0.2%	53
2021 Q1	$401K	Buy	2,957 +1,284	+77%	+$192K	0.32%	37
2020 Q4	$235K	Buy	+1,673	New	+$214K	0.22%	46

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Round Rock Advisors's XBI Position: Q1 2026 in Review

Round Rock Advisors reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 2.6% in Q1 2026, selling an estimated $7.49K and leaving 2,219 shares worth $283K. The position accounts for 0.04% of the portfolio, ranked #268.

Round Rock Advisors first reported a position in XBI in Q4 2020 and has held it in 15 quarters since. The position peaked at $583K in Q4 2022. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Round Rock Advisors held 2,219 shares of State Street SPDR S&P Biotech ETF worth $283K as of Q1 2026.
Round Rock Advisors sold 60 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $7.49K.
State Street SPDR S&P Biotech ETF made up 0.04% of Round Rock Advisors's portfolio in Q1 2026, its #268 holding.
Round Rock Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 15 quarters since.
Round Rock Advisors's State Street SPDR S&P Biotech ETF position peaked at $583K in Q4 2022.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Round Rock Advisors's 13F filing for Q1 2026, filed 15 May 2026.